Physician network position and patient outcomes following implantable cardioverter defibrillator therapy

被引:9
作者
Moen, Erika L. [1 ,2 ]
Bynum, Julie P. [3 ]
Skinner, Jonathan S. [4 ,5 ]
O'Malley, Alistair J. [1 ,2 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[4] Dept Econ, Hanover, NH USA
[5] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
关键词
case fatality; degree centrality; implantable cardioverter defibrillator; physician network; OPERATIVE MORTALITY; HOSPITAL VOLUME; SHARING NETWORKS; SEX-DIFFERENCES; SURGEON VOLUME; COMPLICATIONS;
D O I
10.1111/1475-6773.13151
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective To evaluate two novel measures of physician network centrality and their associations with implantable cardioverter defibrillator (ICD) procedure volume and health outcomes. Data Sources Medicare claims and the National Cardiovascular Data Registry data from 2007 to 2011. Study Design We constructed a national cardiovascular disease patient-sharing physician network and used network analysis to characterize physician network centrality with two measures: within-hospital degree centrality (number of connections within a hospital) and across-hospital degree centrality (number of connections across hospitals). The primary outcome was risk-adjusted 2-year case fatality. Hierarchical logistic regression estimated the effects of physician's within-hospital and across-hospital degree centrality on case fatality. We included 105 109 ICD therapy patients and 3474 ICD implanting physicians in our analyses. Principal Findings After controlling for other physician and hospital characteristics, we observed greater risk-adjusted case fatality among patients treated by physicians in the highest across-hospital degree tertile compared to lowest tertile (OR [95% CI] = 1.10 [1.04-1.16], P = 0.001) and lowest tertile volume physicians compared with highest volume (OR [95% CI] = 0.90 [0.84-0.95], P < 0.001). Physician's within-hospital degree tertile was inversely associated with case fatality but not statistically significant. Conclusions Degree centrality measures capture information independent of procedure volume and raise questions about the quality of physicians with networks that predict worse health outcomes.
引用
收藏
页码:880 / 889
页数:10
相关论文
共 50 条
[31]   Gender Bias Trends in Implantable Cardioverter-Defibrillator Therapy [J].
Sahni S. ;
Fonarow G.C. .
Current Cardiovascular Risk Reports, 2014, 8 (3) :1-6
[32]   Implantable Cardioverter Defibrillator Therapy for Prevention of Sudden Cardiac Death in Children in The Netherlands [J].
Heersche, Jogien H. M. ;
Blom, Nico A. ;
Van De Heuvel, Freek ;
Blank, Christiaan ;
Reimer, Annette G. ;
Clur, Sally-Ann ;
Witsenburg, Maarten ;
Ten Harkel, A. Derk Jan .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (02) :179-185
[33]   Implantable cardioverter defibrillator therapy in children with long QT syndrome [J].
Goel, AK ;
Berger, S ;
Pelech, A ;
Dhala, A .
PEDIATRIC CARDIOLOGY, 2004, 25 (04) :370-378
[34]   Holiday Shocker: An Unusual Cause of Implantable Cardioverter Defibrillator Therapy [J].
Carpenter, Viki ;
Pugh, Peter J. ;
Martin, Claire A. .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (09) :1114-1116
[35]   Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs [J].
Singh, Steven ;
Murawski, Matthew M. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 12 (03) :175-180
[36]   Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients [J].
Alter, P ;
Waldhans, S ;
Plachta, E ;
Moosdorf, R ;
Grimm, W .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09) :926-932
[37]   Improving implantable cardioverter defibrillator therapy through better programming [J].
Kutyifa, Valentina ;
Moss, Arthur J. ;
Zareba, Wojciech .
EXPERT REVIEW OF MEDICAL DEVICES, 2013, 10 (03) :283-285
[38]   The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives [J].
Daeschler, Margaret ;
Verdino, Ralph J. ;
Kirkpatrick, James N. .
EUROPACE, 2017, 19 (08) :1343-1348
[39]   Complications of third-generation implantable cardioverter defibrillator therapy [J].
Grimm, W ;
Menz, V ;
Hoffmann, J ;
Timmann, U ;
Funck, R ;
Moosdorf, R ;
Maisch, B .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (01) :206-211
[40]   The effect of device advisories on implantable cardioverter-defibrillator therapy [J].
Amin M.S. ;
Ellenbogen K.A. .
Current Cardiology Reports, 2010, 12 (5) :361-366